These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 26105582

  • 1. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis.
    Noureldein MH, Abd El-Razek RS, El-Hefnawy MH, El-Mesallamy HO.
    Diabetes Res Clin Pract; 2015 Sep; 109(3):513-20. PubMed ID: 26105582
    [Abstract] [Full Text] [Related]

  • 2. Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus.
    Zhou ZW, Ju HX, Sun MZ, Chen HM, Fu QP, Jiang DM.
    Clin Chim Acta; 2018 Jan; 476():98-102. PubMed ID: 29174342
    [Abstract] [Full Text] [Related]

  • 3. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
    El-Deeb TS, Bakkar SM, Eltoony L, Zakhary MM, Kamel AA, Nafee AM, Hetta HF.
    Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
    [Abstract] [Full Text] [Related]

  • 4. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS, Lee JJ, Kim Y, Kim IS, Zhang WY, Myung CS.
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [Abstract] [Full Text] [Related]

  • 5. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment.
    Haluzík MM, Anderlová K, Doležalová R, Adamíková A, Haluzíková D, Housová J, Svacina S, Haluzík M.
    Physiol Res; 2009 Apr; 58(1):93-99. PubMed ID: 18198986
    [Abstract] [Full Text] [Related]

  • 6. Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
    Yang PJ, Ser KH, Lin MT, Nien HC, Chen CN, Yang WS, Lee WJ.
    Obes Surg; 2015 Dec; 25(12):2328-34. PubMed ID: 25933632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
    Reinehr T, Karges B, Meissner T, Wiegand S, Fritsch M, Holl RW, Woelfle J.
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
    [Abstract] [Full Text] [Related]

  • 9. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
    Zhou ZW, Ju HX, Sun MZ, Fu QP, Chen HM, Ji HB, Ji F, Jiang DM.
    Clin Chim Acta; 2016 Apr 01; 455():113-7. PubMed ID: 26851648
    [Abstract] [Full Text] [Related]

  • 10. Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.
    Kavalkova P, Touskova V, Roubicek T, Trachta P, Urbanova M, Drapalova J, Haluzikova D, Mraz M, Novak D, Matoulek M, Lacinova Z, Haluzik M.
    Horm Metab Res; 2013 Oct 01; 45(11):820-6. PubMed ID: 23979788
    [Abstract] [Full Text] [Related]

  • 11. Serum fetuin-A and arginase-1 in human obesity model: Is there any interaction between inflammatory status and arginine metabolism?
    Tanrikulu-Küçük S, Koçak H, Öner-İyidoğan Y, Seyithanoğlu M, Topparmak E, Kayan-Tapan T.
    Scand J Clin Lab Invest; 2015 Jul 01; 75(4):301-7. PubMed ID: 25723054
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.
    Esteghamati A, Afarideh M, Feyzi S, Noshad S, Nakhjavani M.
    Diabetes Metab Syndr; 2015 Jul 01; 9(4):258-65. PubMed ID: 25450818
    [Abstract] [Full Text] [Related]

  • 13. Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients.
    Ozyazgan S, Karaoglu K, Kurt A, Altinok A, Konukoglu D, Osar Siva Z, Andican G.
    Minerva Med; 2013 Jun 01; 104(3):287-93. PubMed ID: 23748282
    [Abstract] [Full Text] [Related]

  • 14. The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Khalili L, Alipour B, Asghari Jafar-Abadi M, Faraji I, Hassanalilou T, Mesgari Abbasi M, Vaghef-Mehrabany E, Alizadeh Sani M.
    Iran Biomed J; 2019 Jan 01; 23(1):68-77. PubMed ID: 29803203
    [Abstract] [Full Text] [Related]

  • 15. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
    Powell LA, Crowe P, Kankara C, McPeake J, McCance DR, Young IS, Trimble ER, McGinty A.
    Clin Sci (Lond); 2012 Aug 01; 123(3):135-46. PubMed ID: 22309242
    [Abstract] [Full Text] [Related]

  • 16. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men.
    Ryan KE, McCance DR, Powell L, McMahon R, Trimble ER.
    Atherosclerosis; 2007 Oct 01; 194(2):e123-30. PubMed ID: 17145061
    [Abstract] [Full Text] [Related]

  • 17. [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
    Zhu HL, Yu RM, Huang XZ, Huang W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun 01; 28(6):1050-1. PubMed ID: 18583261
    [Abstract] [Full Text] [Related]

  • 18. PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.
    Feng X, Gao X, Jia Y, Zhang H, Xu Y, Wang G.
    Med Sci Monit; 2016 Mar 05; 22():743-51. PubMed ID: 26944934
    [Abstract] [Full Text] [Related]

  • 19. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation.
    Khadir A, Kavalakatt S, Madhu D, Hammad M, Devarajan S, Tuomilehto J, Tiss A.
    Lipids Health Dis; 2018 Dec 22; 17(1):291. PubMed ID: 30579336
    [Abstract] [Full Text] [Related]

  • 20. Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    Zhang LY, Qu XN, Sun ZY, Zhang Y.
    Clin Res Hepatol Gastroenterol; 2020 Oct 22; 44(5):674-680. PubMed ID: 32113823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.